Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

389
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
389
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

252
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal trends in baseline severity and 12-month response to mepolizumab in severe asthma: The TYREX multicentre real-world study in Spain (2017-2024).

Respiratory medicine·2026
Same author

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) mimicking poorly controlled asthma: CT findings.

Medicina clinica·2026
Same author

Evaluating mepolizumab and dupilumab for severe chronic rhinosinusitis with nasal polyps: insights from a real-life study.

Acta otorrinolaringologica espanola·2026
Same author

[Translated article] Designing a patient onboarding in a multidisciplinary severe asthma unit.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2025
Same author

Designing a patient onboarding in a multidisciplinary severe asthma unit.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2025
Same author

Optimizing diagnostic and management pathways for patients with eosinophilia of unknown origin: a multidisciplinary protocol for urgent and non-urgent evaluation.

Frontiers in medicine·2025

Related Experiment Video

Updated: Jun 27, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

[Asthma].

Celia Pinedo Sierra1, Elena Curto Sánchez2, Rocio Diaz Campos3

  • 1Servicio de Neumología. Hospital Universitario Clínico San Carlos. Universidad Complutense, Madrid, España.

Open Respiratory Archives
|May 6, 2024
PubMed
Summary
This summary is machine-generated.

Asthma management needs better biomarkers for diagnosis and treatment. Identifying these biomarkers is crucial for personalized medicine in severe allergic and eosinophilic asthma cases.

Keywords:
AsthmaBiologicsBiomarkersOccupational asthma

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.0K

Related Experiment Videos

Last Updated: Jun 27, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.0K

Area of Science:

  • Respiratory Medicine
  • Immunology
  • Biomarker Discovery

Context:

  • Asthma affects 5% globally, causing significant health and social burdens.
  • Severe asthma impacts 18% in Western Europe, with 50% experiencing poor control.
  • Current guidelines classify severe asthma into T2 (allergic/eosinophilic) and non-T2 phenotypes.

Purpose:

  • To highlight the need for objective diagnostic measures and risk assessment in asthma management.
  • To emphasize the importance of identifying biomarkers for predicting asthma severity, disease course, and treatment response.
  • To discuss the potential of omics technologies in discovering novel asthma biomarkers.

Summary:

  • Asthma requires precise diagnosis and management, including symptom control and exacerbation risk assessment.
  • Personalized treatments based on asthma phenotypes (T2 vs. non-T2) are advancing with new biological therapies.
  • Biomarker identification is essential for tailoring treatments, but current clinical applications are limited, with omics technologies in early research stages.

Impact:

  • Improved asthma diagnosis and personalized treatment strategies.
  • Enhanced prediction of disease progression and therapeutic outcomes.
  • Advancement of precision medicine in respiratory diseases through biomarker research.